Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Fexuclue (fexuprazan) and rabeprazole for treatment of peptic ulcer
KCT0008647Phase 4Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fexuprazan, rabeprazole in Peptic ulcer disease (PUD), sponsored by Daewoong Pharmaceutical. Started Sep 2023; status: completed.
02
Drugs
fexuprazanrabeprazole
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on KCT0008647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008647.